What’s new

• FY26 revenue rose 3.7% to ₹5,675 crore.
• Net profit grew 21.3% to ₹689 crore, outpacing sales growth.
• Board recommends final dividend of ₹60 per share.

Why it matters

Profit grew almost six times faster than revenue. The results are routine, but the spread between top-line and bottom-line growth is wide enough to invite questions about what changed in the cost structure. The ₹60 dividend is a straightforward cash return.

What we’re watching

• Whether cost savings are permanent or driven by one-time items.
• Management commentary on input costs for FY27.
• Capex plans for new molecules or formulation capacity.

The full read

Bayer CropScience closed FY26 with revenue of ₹5,675 crore, up 3.7%. The bottom line grew far faster: net profit of ₹689 crore marks a 21.3% jump. That spread is wide. A company growing sales at under 4% and profits at over 20% is either cutting costs hard, repricing products, or both. The filing does not say which. The board also recommended a final dividend of ₹60 per share. These are standard annual results. They were anticipated, and they contained no surprises or guidance changes to force analyst model revisions. The open question is whether the cost discipline behind the profit surge is structural or a one-off.

Primary source: BSE · NSE